Memorial Sloan Kettering Cancer Center Debuts “One Hundred Views” Mural in Collaboration with Artist Naomi Reis and Local P.S. 183 Fifth-Grade Students | Newswise

Memorial Sloan Kettering Cancer Center Debuts “One Hundred Views” Mural in Collaboration with Artist Naomi Reis and Local P.S. 183 Fifth-Grade Students | Newswise

Newswise — NEW YORK, NY, March 5, 2025—Memorial Sloan Kettering Cancer Center (MSK) is proud to announce a new community mural, “One Hundred Views,” by artist Naomi Reis. The inaugural MSK mural was created in collaboration with fifth-grade students from P.S. 183 Robert L. Stevenson Elementary School, the neighboring school on East 66th Street. This…

Read More
Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50 | Newswise

Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50 | Newswise

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025. Dr. Balachandran was selected for his groundbreaking…

Read More
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others | Newswise

Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others | Newswise

BYLINE: Julie Grisham Newswise — Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth. Medical oncologists use information about the genetic mutations found in tumors to match patients with…

Read More
Top Cancer Research Advances at MSK in 2024 | Newswise

Top Cancer Research Advances at MSK in 2024 | Newswise

Newswise — Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights into human biology and disease. “Patients come to MSK seeking the very best…

Read More